# A Study to Assess 18-Methoxycoronaridine (18-MC HCl) in Healthy Volunteers

> **NCT04292197** · PHASE1 · COMPLETED · sponsor: **Definium Therapeutics US, Inc.** · enrollment: 108 (actual)

## Conditions studied

- Addiction

## Interventions

- **DRUG:** 18-MC Compound

## Key facts

- **NCT ID:** NCT04292197
- **Lead sponsor:** Definium Therapeutics US, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-14
- **Primary completion:** 2021-12-13
- **Final completion:** 2021-12-31
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2022-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04292197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04292197, "A Study to Assess 18-Methoxycoronaridine (18-MC HCl) in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04292197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*